Literature DB >> 33334036

Associations between Clinical Symptoms and Degree of Ossification in Patients with Cervical Ossification of the Posterior Longitudinal Ligament: A Prospective Multi-Institutional Cross-Sectional Study.

Takashi Hirai1,2, Toshitaka Yoshii1,2, Shuta Ushio1,2, Jun Hashimoto1,2, Kanji Mori2,3, Satoshi Maki2,4, Keiichi Katsumi2,5, Narihito Nagoshi2,6, Kazuhiro Takeuchi2,7, Takeo Furuya2,4, Kei Watanabe2,5, Norihiro Nishida2,8, Soraya Nishimura2,6, Kota Watanabe2,6, Takashi Kaito2,9, Satoshi Kato2,10, Katsuya Nagashima2,11, Masao Koda2,11, Kenyu Ito2,12, Shiro Imagama2,12, Yuji Matsuoka2,13, Kanichiro Wada2,14, Atsushi Kimura2,15, Tetsuro Ohba2,16, Hiroyuki Katoh2,17, Masahiko Watanabe2,17, Yukihiro Matsuyama2,18, Hiroshi Ozawa2,19, Hirotaka Haro2,16, Katsushi Takeshita2,15, Morio Matsumoto2,6, Masaya Nakamura2,6, Masashi Yamazaki2,11, Masato Yuasa1,2, Hiroyuki Inose1,2, Atsushi Okawa1,2, Yoshiharu Kawaguchi2,20.   

Abstract

This study aimed to clarify whether ossification predisposition influences clinical symptoms including pain, restriction of activities of daily living, and quality of life in patients with cervical ossification of the posterior longitudinal ligament (OPLL). Cervical ossification predisposition potentially causes neurologic dysfunction, but the relationship between clinical symptoms and radiologic severity of OPLL has not yet been investigated. Data were prospectively collected from 16 institutions across Japan. We enrolled 239 patients with cervical OPLL. The primary outcomes were patient-reported outcomes, including visual analog scale (VAS) pain scores and other questionnaires. Whole-spine computed tomography images were obtained, and correlations were investigated between clinical symptoms and radiologic findings, including the distribution of OPLL, the sum of the levels where OPLL was present (OP-index), and the canal narrowing ratio (CNR) grade. The cervical OP-index was Grade 1 in 113 patients, Grade 2 in 90, and Grade 3 in 36. No significant correlations were found between radiologic outcomes and VAS pain scores. The cervical OP-index was associated with lower extremity function, social dysfunction, and locomotive function. The CNR grade was not correlated with clinical symptoms, but Grade 4 was associated with lower extremity dysfunction. Thickness and extension of ossified lesions may be associated with lower extremity dysfunction in cervical OPLL.

Entities:  

Keywords:  OP-index; activities of daily living; canal narrowing ratio; computed tomography; ossification of the posterior longitudinal ligament (OPPL); pain; patient-reported outcomes; quality of life; spinal disorder

Year:  2020        PMID: 33334036     DOI: 10.3390/jcm9124055

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  2 in total

1.  Clinical Characteristics of Patients with Ossification of the Posterior Longitudinal Ligament and a High OP Index: A Multicenter Cross-Sectional Study (JOSL Study).

Authors:  Takashi Hirai; Toshitaka Yoshii; Jun Hashimoto; Shuta Ushio; Kanji Mori; Satoshi Maki; Keiichi Katsumi; Narihito Nagoshi; Kazuhiro Takeuchi; Takeo Furuya; Kei Watanabe; Norihiro Nishida; Soraya Nishimura; Kota Watanabe; Takashi Kaito; Satoshi Kato; Katsuya Nagashima; Masao Koda; Hiroaki Nakashima; Shiro Imagama; Kazuma Murata; Yuji Matsuoka; Kanichiro Wada; Atsushi Kimura; Tetsuro Ohba; Hiroyuki Katoh; Masahiko Watanabe; Yukihiro Matsuyama; Hiroshi Ozawa; Hirotaka Haro; Katsushi Takeshita; Morio Matsumoto; Masaya Nakamura; Satoru Egawa; Yu Matsukura; Hiroyuki Inose; Atsushi Okawa; Masashi Yamazaki; Yoshiharu Kawaguchi
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

2.  Hsa-circ-0007292 promotes the osteogenic differentiation of posterior longitudinal ligament cells via regulating SATB2 by sponging miR-508-3p.

Authors:  Anlong Jiang; Nanxiang Wang; Xinxing Yan; Yunheng Jiang; Chengchao Song; Hui Chi; Guanghua Chen; Feng Wu; Ye Ji; Jinglong Yan
Journal:  Aging (Albany NY)       Date:  2021-08-23       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.